ANI Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ANIP
CUSIP
00182C103
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 233 20.0 M $1.35 B
2024 Q4 209 19.3 M $1.07 B
2024 Q3 213 19.5 M $1.17 B
2024 Q2 209 15.6 M $994 M
2024 Q1 210 14.8 M $1.03 B
2023 Q4 190 14.1 M $778 M
2023 Q3 193 13.2 M $767 M
2023 Q2 177 12.3 M $662 M
2023 Q1 144 10.5 M $417 M
2022 Q4 133 10.7 M $431 M
2022 Q3 129 10.3 M $330 M
2022 Q2 125 9.88 M $293 M
2022 Q1 131 9.21 M $259 M
2021 Q4 143 8.99 M $414 M
2021 Q3 122 7.28 M $239 M
2021 Q2 121 7.21 M $253 M
2021 Q1 111 7.31 M $264 M
2020 Q4 126 7.80 M $227 M
2020 Q3 124 7.31 M $206 M
2020 Q2 142 7.47 M $241 M
2020 Q1 153 7.99 M $325 M
2019 Q4 184 8.22 M $507 M
2019 Q3 209 9.14 M $666 M
2019 Q2 215 8.97 M $738 M
2019 Q1 204 7.72 M $544 M
2018 Q4 180 7.18 M $323 M
2018 Q3 189 7.76 M $438 M
2018 Q2 196 7.36 M $492 M
2018 Q1 190 6.80 M $396 M
2017 Q4 177 6.54 M $422 M
2017 Q3 158 6.41 M $337 M
2017 Q2 165 6.50 M $305 M
2017 Q1 176 6.47 M $321 M
2016 Q4 173 6.28 M $381 M
2016 Q3 184 6.04 M $401 M
2016 Q2 151 5.61 M $313 M
2016 Q1 132 5.81 M $195 M
2015 Q4 132 6.32 M $285 M
2015 Q3 128 6.99 M $280 M
2015 Q2 132 6.49 M $403 M
2015 Q1 134 6.96 M $435 M
2014 Q4 103 5.63 M $317 M
2014 Q3 74 4.54 M $129 M
2014 Q2 83 4.58 M $157 M
2014 Q1 68 3.79 M $118 M